Biomea Fusion Inc is a preclinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of irreversible small molecule drugs to treat patients with genetically defined cancers. The companies lead product candidate, BMF-219, is designed to be an orally bioavailable, potent and selective irreversible inhibitor of menin, an important transcriptional regulator known to play a direct role in oncogenic signaling in multiple cancers.

Earnings

see more
Q2 2021Est.ActualSurprise
EPS
(EXPECTED)2021-08-03
REV
Q1 2021Est.ActualSurprise
EPS-0.490
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
BMEABiomea Fusion-1.53%

Biomea Fusion Frequently Asked Questions

Q

How do I buy Biomea Fusion (BMEA) stock?

A

You can purchase shares of Biomea Fusion (NASDAQ: BMEA) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Biomea Fusion's (BMEA) competitors?

A

There are no as such competitors for Biomea Fusion.

Q

What is the target price for Biomea Fusion (BMEA) stock?

A

The latest price target for Biomea Fusion (NASDAQ: BMEA) was reported by Jefferies on May 11, 2021. The analyst firm set a price target for 26.00 expecting BMEA to rise to within 12 months (a possible 26.15% upside). 3 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Biomea Fusion (BMEA)?

A

The stock price for Biomea Fusion (NASDAQ: BMEA) is $20.61 last updated Fri Jun 11 2021 20:00:03 GMT+0000 (Coordinated Universal Time).

Q

Does Biomea Fusion (BMEA) pay a dividend?

A

There are no upcoming dividends for Biomea Fusion.

Q

When is Biomea Fusion (NASDAQ:BMEA) reporting earnings?

A
Biomea Fusion’s Q2 earnings are confirmed for after-market on August 3, 2021.
Q

Is Biomea Fusion (BMEA) going to split?

A

There is no upcoming split for Biomea Fusion.

Q

What sector and industry does Biomea Fusion (BMEA) operate in?

A

Biomea Fusion is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.